Medmain is a technology company that develops software for pathology diagnosis. It offers PidPort, an AI-driven platform for rapid pathology analysis and remote telepathology consultations, and Medteria, an online education portal for medical students. The cloud-based platform supports deep learning–driven screening, secure storage, and remote diagnostics to help medical institutions and professionals enhance diagnostic accuracy and efficiency and improve patient care. Founded in 2018 and based in Fukuoka, Japan, with offices in Tokyo and the United States, Medmain focuses on expanding access to expert pathology services through technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.